SARS-CoV-2 S-specific binding antibody titres. Since the vast majority of participants will have a (very) high antibody titre after vaccination, the samples will be diluted until the exact titre (U/mL) is known. This will allow calculation of the anti-S antibody half-life.

SARS-CoV-2 S-specific binding antibody titres. Since the vast majority of participants will have a (very) high antibody titre after vaccination, the samples will be diluted until the exact titre (U/mL) is known. This will allow calculation of the anti-S antibody half-life.